26
IRUS Total
Downloads
  Altmetric

Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity

File Description SizeFormat 
Revised Supplemental Figures.pdfSupplementary information1.28 MBAdobe PDFView/Open
jem_20201555.pdfPublished version6.37 MBAdobe PDFView/Open
Title: Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity
Authors: Pyle, CJ
Labeur-Iurman, L
Groves, HT
Puttur, F
Lloyd, CM
Tregoning, JS
Harker, JA
Item Type: Journal Article
Abstract: T follicular helper cell (TFH)-dependent antibody responses are critical for long-term immunity. Antibody responses are diminished in early life, limiting long-term protective immunity and allowing prolonged or recurrent infection, which may be important for viral lung infections that are highly prevalent in infancy. In a murine model using respiratory syncytial virus (RSV), we show that TFH and the high-affinity antibody production they promote are vital for preventing disease on RSV reinfection. Following a secondary RSV infection, TFH-deficient mice had significantly exacerbated disease characterized by delayed viral clearance, increased weight loss, and immunopathology. TFH generation in early life was compromised by heightened IL-2 and STAT5 signaling in differentiating naive T cells. Neutralization of IL-2 during early-life RSV infection resulted in a TFH-dependent increase in antibody-mediated immunity and was sufficient to limit disease severity upon reinfection. These data demonstrate the importance of TFH in protection against recurrent RSV infection and highlight a mechanism by which this is suppressed in early life.
Issue Date: 6-Dec-2021
Date of Acceptance: 23-Sep-2021
URI: http://hdl.handle.net/10044/1/92500
DOI: 10.1084/jem.20201555
ISSN: 0022-1007
Publisher: Rockefeller University Press
Journal / Book Title: Journal of Experimental Medicine
Volume: 218
Issue: 12
Copyright Statement: © 2021 Pyle et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Sponsor/Funder: Wellcome Trust
Asthma UK
National Heart & Lung Institute Foundation
Funder's Grant Number: 101372/Z/13/Z
Asthma UK Centre
Students 2016-19
Keywords: Immunology
11 Medical and Health Sciences
Publication Status: Published
Conference Place: United States
Article Number: ARTN e20201555
Online Publication Date: 2021-10-19
Appears in Collections:Department of Infectious Diseases
National Heart and Lung Institute
Faculty of Medicine



This item is licensed under a Creative Commons License Creative Commons